SPY425.10+2.50 0.59%
DIA341.98+3.20 0.94%
IXIC14,369.71+97.98 0.69%

BRIEF-Inovio Pharmaceuticals Plans To Start Global Phase 3 Trial For COVID-19 Vaccine Candidate This Summer

05/10/2021 16:26
BRIEF-Inovio Pharmaceuticals Plans To Start Global Phase 3 Trial For COVID-19 Vaccine Candidate This Summer

- Inovio Pharmaceuticals Inc INO.O:

  • INOVIO REPORTS FIRST QUARTER 2021 FINANCIAL RESULTS

  • Q1 LOSS PER SHARE $0.27

  • Q1 EARNINGS PER SHARE ESTIMATE $-0.18 -- REFINITIV IBES DATA

  • ASSESSING IMPACT THAT NEW CIRCULATING STRAINS OF SARS-COV-2 VIRUS HAVE ON IMMUNE PROFILE ELICITED BY INO-4800

  • PLANS TO INITIATE GLOBAL PHASE 3 TRIAL FOR INO-4800 THIS SUMMER

  • INOVIO - DEVELOPING NOVEL, PAN-COVID, SECOND-GENERATION VACCINE CANDIDATE, INO-4802, DESIGNED TO PROTECT AGAINST CURRENT, POTENTIALLY FUTURE VARIANTS

Source text for Eikon: ID:nPn31dVBYa

Further company coverage: INO.O


(([email protected];))